About Me
About Me
May 2013
Emory University
Bachelor of Science (BS) in Biology
–
April 2019
St. George's University School of Medicine
Medical Doctorate (MD)
–
May 2023
Weill Cornell Medicine
Master of Science (MS) in Clinical Investigation
–
In Progress
KU Leuven
Doctor of Philosophy (PhD) in Microbiology and Immunology
June 2020
Icahn School of Medicine at Mount Sinai (Elmhurst)
Internal Medicine (Intern year)
–
June 2023
Weill Cornell Medicine (New York Presbyterian Hospital)
Nuclear Medicine
–
In Progress
Albert Einstein College of Medicine (Montefiore Medical Center)
Radiation Oncology
Subramanian K, Ivanidze J, Paris M, Ricaurte Fajardo A, Osborne JR. Alternate CMS Payment Structure for Outpatient Services: A Road to Improving Access to Molecular Imaging in Oncologic Care. Radiol Imaging Cancer. 2023 Nov;5(6):e230166. doi: 10.1148/rycan.230166. PMID: 37947587; PMCID: PMC10701460.
Subramanian K, Osborne JR. PSMA PET/CT cost-effectiveness analysis in the USA: a response to a published commentary. Eur J Nucl Med Mol Imaging. 2023 Oct;50(12):3509-3510. doi: 10.1007/s00259-023-06378-y. Epub 2023 Aug 4. PMID: 37540238.
Subramanian, K., Muench, B., Shostak E., Coffey A., Sawoszcyk, L., Gao, F. et al. (2023) Lobar quantification of pulmonary perfusion prior to minimally invasive lung reduction improves prediction of postprocedure outcomes: a pilot study. Clinical Physiology and Functional Imaging. doi:10.1111/cpf.12847
Subramanian K, Martinez J, Castellanos SH, Ivanidze J, Nagar H, Nicholson S, Youn T, Nauseef JT, Tagawa S, Osborne JR. Complex implementation factors demonstrated when evaluating cost-effectiveness and monitoring racial disparities associated with [18F]DCFPyL PET/CT in prostate cancer men. Sci Rep. 2023 May 23;13(1):8321. doi: 10.1038/s41598-023-35567-w. PMID: 37221397; PMCID: PMC10205741.
Subramanian K, Stangl-Kremser J, Sawoszczyk L, et al. α-Labeling of J591, an Antibody Targeting Prostate-Specific Membrane Antigen: The Technique and Considerations from the First Dedicated Production Lab at an Academic Institution in the United States. J Nucl Med Technol. Published online April 25, 2023:jnmt.122.265166. doi:10.2967/jnmt.122.265166
Stangl‐Kremser J, Ricaurte‐Fajardo A, Subramanian K, et al. Response to RL‐225Ac in prostate cancer: Effect of prior treatment with RL‐177Lu: A systematic review of the literature. The Prostate. Published online April 13, 2023:pros.24531. doi:10.1002/pros.24531
Martinez J, Subramanian K, Castellanos SH, et al. Cyclotron vs generator-produced 68Ga PSMA: a single-institution, prospective clinical trial. Transl Oncol. 2023 Feb;28:101593. doi: 10.1016/j.tranon.2022.101593. Epub 2022 Dec 24. PMID: 36571987; PMCID: PMC9803810.